Shah Capital, which has agitated for change at the vaccine maker for years, is calling on fellow shareholders to end what it ...

YieldMax MRNA Option Income Strategy ETF is rated a Sell due to heightened downside risk and overvalued pipeline optimism.

Katalin Karikó, a Nobel Prize-winning scientist who pioneered mRNA research that led to life-saving vaccines during the COVID ...

"Your tenure has overseen a DESTRUCTION of shareholder value—a direct result of chronic operational shortcomings and failures ...

"We're just scratching the surface in terms of what they covered up," Permanent Subcommittee on Investigations chair says.

After shedding expensive commercial infrastructure and pivoting to a partnership model, the company is now positioning its ...

Penn Medicine scientists blend AI and ingenuity to transform mRNA gene editing and personalized therapies redefining modern ...

Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious ...

Gronvall reminded the audience there are currently two vaccines that do work to prevent cancer: the hepatitis B vaccine given ...

COVID-19 vaccination during pregnancy protected infants up to 6 months after birth, according to a study published recently ...

Vaccine makers Pfizer and BioNTech halted a large U.S. trial of their updated COVID-19 ​vaccine in healthy adults aged 50 to ...

A Belgian court on Wednesday ordered ​Poland and Romania to take delivery of 1.9 billion euros ($2.2 billion) worth of ...